The Mercury News

Young kids not likely to experience heart issues

- By Lauran Neergaard

Is the COVID-19 vaccine safe for children?

Yes, U.S. regulators say after they authorized Pfizer’s vaccine for younger children after millions of 12- to 17-year-olds already safely got the shot, the only one available for children in the country.

Those ages 5 to 11 will get just a third of the dose given to teens and adults. The Food and Drug Administra­tion cleared the kid-size doses Friday, and next the Centers for Disease Control and Prevention will recommend who should get them.

A study found kid-size doses of the Pfizer-BioNTech vaccine were 91% effective at preventing symptomati­c COVID-19. The 5- to 11-year-olds developed virus-fighting antibodies as strong as those of teens and young adults who got regular doses, with similar or fewer annoying reactions such as sore arms, fever or achiness.

The FDA assessed the safety of the kid-size doses in 3,100 vaccinated youngsters. Regulators deemed that enough data, considerin­g the trove of safety informatio­n from hundreds of millions of larger doses given to adults and teens worldwide.

Very rarely, teens and young adults given the Pfizer-BioNTech vaccine or a similar one made by Moderna experience a serious side effect, heart inflammati­on, or what doctors call myocarditi­s. It’s mostly in young men or teen boys and usually after the second dose. They tend to recover quickly, and after intense scrutiny U.S. health authoritie­s concluded the vaccine’s benefits outweigh that small risk.

To put the risk in context, COVID-19 also causes heart inflammati­on, often a more severe kind, said Dr. Matthew Oster, a pediatric cardiologi­st at Emory University. It also sometimes occurs in children who get a multisyste­m inflammato­ry syndrome after a coronaviru­s infection.

Before the pandemic, doctors regularly diagnosed heart inflammati­on caused by bacterial or viral infections or medication­s, again mostly in teen boys and young men. Oster said one theory is that testostero­ne and puberty play a role, which is partly why many experts expect any vaccine-related risk would be lower for younger kids getting a smaller dose.

Newspapers in English

Newspapers from United States